
Encoxel 40 Injection
Marketer
Celon Laboratories Ltd
Salt Composition
Enoxaparin (40mg)
Overview Encoxel 40 Injection
Heparinoid 40 Injection is an antithrombotic agent employed to prevent and manage dangerous blood clots. It inhibits the growth of existing clots and prevents the development of new ones. This medication is also beneficial in preventing venous thromboembolism, encompassing deep vein thrombosis and pulmonary embolism. Administration of Heparinoid 40 Injection is subcutaneous, performed by a healthcare professional; intramuscular injection is contraindicated. Dosage and treatment duration are individualized, considering the patient's medical history, response to therapy, and specific condition, along with age and weight. Continuous use is crucial, even in the absence of symptoms, as it safeguards against future complications. Discontinuation may lead to clot formation. Activities increasing bleeding risk or injury should be avoided during treatment. Common adverse effects include injection site discomfort, hemorrhage, cephalalgia, thrombocytosis, respiratory distress, swelling, anemia, pyrexia, bowel looseness, and elevated liver function tests. Severe headache may indicate intracranial bleeding, while intense abdominal pain could suggest gastrointestinal hemorrhage. Bleeding, potentially subtle, is a serious risk; prompt reporting of concerning symptoms is essential. Prior to initiating therapy, inform your physician of pre-existing hypertension, diabetes, or recent cerebrovascular accident. The medication is contraindicated in active bleeding. Concomitant medications should be disclosed to ensure safety. Patients with low body mass may exhibit heightened bleeding susceptibility; alcohol consumption increases the risk of gastrointestinal bleeding.
Primary Ingredients of Encoxel 40 Injection
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Encoxel 40 Injection
Preventing and managing blood clot formation.
Major Benefits of Encoxel 40 Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is not permitted.
Common Side effects of Encoxel 40 Injection:
- Bleeding
- Headache
- Low blood platelets
- Increased liver enzymes
- Anemia (low number of red blood cells)
- Fever
- Injection site pain
- Breathing problems
- Edema (swelling)
- Diarrhea
How to use Encoxel 40 Injection:
The medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Encoxel 40 Injection works:
Encoxel 40 Injection is a medication that thins the blood. Its mechanism involves neutralizing specific coagulation factors, thus inhibiting clot development and preventing vascular obstructions.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The safety of combining alcohol with Encoxel 40 Injection is undetermined. Seek medical advice before mixing them.
PregnancySAFE IF PRESCRIBED
The use of Encoxel 40 Injection during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harmful consequences for fetal development; nonetheless, data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Encoxel 40 Injection safely. Studies in humans indicate minimal risk to the infant. The drug's transfer to breast milk is negligible, resulting in insignificant quantities reaching the baby, posing no apparent harm.
DrivingSAFE
Driving ability is typically unaffected by Encoxel 40 Injection.
KidneyCAUTION
Patients with kidney impairment should use Encoxel 40 Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Encoxel 40 Injection's use in individuals with hepatic impairment. Physician consultation is recommended. Patients with pre-existing liver conditions should receive this medication with careful consideration.
What if you forget to take Encoxel 40 Injection :
Should you forget a scheduled Encoxel 40 Injection, seek your physician's advice.
Facts to Know About Encoxel 40 Injection
| Label | Value |
|---|---|
| Chemical Classification | Low-molecular-weight heparin |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Behavior Class | Low-molecular-weight heparin (LMWH) |
